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OBJECTIVES: Psoriasis is a hyperproliferative chronic inflammatory skin disease of unknown etiology and ocular
structures and visual pathways can also be affected during the course of this disease. Subclinical optic neuritis
has previously been observed in psoriatic patients in visual evoked potential studies. This trial was designed to
evaluate retinal sensitivity in patients with psoriasis vulgaris.
METHODS: A total of 40 eyes of 40 patients with chronic plaque-type psoriasis and 40 eyes of 40 age- and sex-
matched control subjects were included in this study. The diagnosis of psoriasis was confirmed by skin biopsy.
The severity was determined using the Psoriasis Area and Severity Index and the duration of the disease was
recorded. After a full ophthalmological examination, including tests for color vision and pupil reactions, the
visual field of each subject was assessed using both standard achromatic perimetry and short wavelength
automated perimetry.
RESULTS: The mean Psoriasis Area and Severity Index was 22.05¡6.409. There were no significant differences
in the visual field parameters of subjects versus controls using either method. There were correlations
between disease severity and the mean deviations in standard achromatic perimetry and short wavelength
automated perimetry and between disease severity and the corrected pattern standard deviation and pattern
standard deviation of short wavelength automated perimetry (r = -0.363, r = -0.399, r = 0.515 and r = 0.369,
respectively).
CONCLUSIONS: Retinal sensitivity appears to be affected by the severity of psoriasis vulgaris.
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& INTRODUCTION
Psoriasis is a hyperproliferative chronic inflammatory
skin disease of unknown etiology. It is characterized by red
and scaly plaques caused by epidermal hyperproliferation.
It has a complex pathogenesis including immune system
alterations and systemic and/or local factors. Psychological
stress, focal infections and some drugs as well as the
activation of leucocytes, which control cellular immunity
and T cell-dependent inflammatory processes, cause the
growth of epidermal and vascular cells in psoriatic skin
lesions (1-6).
Ocular structures and visual pathways can also
be affected in patients suffering from psoriasis (4,7).
Subclinical optic neuritis has previously been shown in
psoriatic patients in visual evoked potential studies.
Elongation of P100 latency and a reduction in the response
amplitude, which designate myelin and axonal involvement
of the optic nerve, have also been observed (8,9).
Electroretinography responses revealed impairment in
overall retinal electrophysiologic functions (10). Visual field
assessment is a functional measurement method that
documents central and peripheral sensitivity of the retina
in both pathological and normal situations (11). Standard
achromatic perimetry (SAP) and short wavelength auto-
mated perimetry (SWAP) use white and blue light stimuli,
respectively, of different sizes and intensities to evaluate the
retinal sensitivity and SWAP was found to be more sensitive
for detecting early visual field changes. In light of these
findings, the objective of this study was to examine the
visual field in psoriatic patients without any pathology of
the retina and/or optic nerve with the aim of evaluating
retinal sensitivity.
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& MATERIALS AND METHODS
A total of 40 eyes of 40 patients with newly diagnosed
plaque-type psoriasis and 40 eyes of 40 age- and sex-
matched control subjects were included in the study. The
diagnosis of psoriasis was based on both histopathological
and clinical findings. The severity was determined using the
Psoriasis Area and Severity Index (PASI) and the duration
of the disease recorded. Possible reasons for exclusion
included the following: a history of neurological diseases,
space-occupying lesions, optic neuropathy, high refractive
errors, glaucoma, retinal pathology, color vision defects and
cataracts, the use of systemic and/or topical retinoic acid or
immunosuppressive medication, and undergoing ultravio-
let therapy. Each patient underwent a full ophthalmological
examination, including measurement of pupil reactions and
application of the Ishihara test for color vision.
All visual field tests were performed using the central 30-
2 threshold strategy with a Humphrey Field Analyzer (750i;
Humphrey Instruments, San Leandro, California, USA) with
SAP (using a Goldmann size III stimulus) and SWAP (using
a Goldmann size V stimulus). Each test was performed by
the same technician and the patients were instructed to rest
before the examination of the other eye. For each subject,
only one eye with reliable visual field parameters (fixation
loss of less than 20%, false positive rate of less than 33%,
false negative rate of less than 33%) was included in the
study. Global indices (mean deviation (MD), pattern
standard deviation (PSD), short-term fluctuation (SF) and
corrected pattern standard deviation (CPSD)) were evalu-
ated. This study was conducted according to the guidelines
of the Declaration of Helsinki and patients provided their
informed consent after the nature and purpose of the study
were fully explained to them.
The Kolmogorov-Smirnov test was used to evaluate
whether the variables were normally distributed. A two-
tailed independent samples t test was used to compare the
ophthalmologic parameters between the experimental and
control groups. A paired sample t-test was used to compare
the ophthalmologic parameters between the SAP and SWAP
methods (separately for each group). A repeated measures
two-way ANOVA was used to analyze differences in the
methods between the experimental and control groups. The
Pearson correlation coefficient was calculated to determine
the significance of the association between two random
variables. Continuous variables are presented as themean¡-
standard deviation. Categorical variables were compared
using the chi-square test and presented as numerical
variables and percentages. A p-value of ,0.05 was consid-
ered significant. Analyses were performed using commercial
software (IBM SPSS Statistics 19; SPSS Inc., an IBM Co.,
Somers, NY, USA).
& RESULTS
Demographic data are summarized in Table 1. There were
no statistically significant intergroup differences in the age
or gender of the patients. None of the study patients has
systemic signs of psoriasis. The ophthalmologic examina-
tions, including color vision tests and pupil reactions,
revealed unremarkable results in both groups. The best
corrected visual acuity was 20/20 in both study groups and
none of the study subjects presented with retinal and/or
optic nerve pathology or ocular pathology. The visual field
parameters are summarized in Table 2. No significant
differences were observed between the two groups; how-
ever, correlations were noted between disease severity
(PASI) and the mean deviations of SAP and SWAP and
between PASI and the CPSD and PSD of SWAP (r = -0.363,
r = -0.399, r = 0.515, and r= 0.369, respectively) (Table 3).
& DISCUSSION
Psoriasis is an organ-specific autoimmune disease that is
characterized by exacerbation and remission (1,4). Psoriasis
activity increases with psychological stress, which has been
explained by the common origin of keratinocytes and
nervous cells during embryogenesis (3,8,9). Any part of
the eye may be affected by psoriasis: the eyelids, con-
junctiva, cornea, uvea, retina, optic nerve and lens may be
involved in the disease process. Ocular symptoms are
reported to occur during exacerbation of the disease (4,7).
The current gold standard for the assessment of psoriasis
severity is PASI, which evaluates the redness, thickness and
scaliness of the lesions. PASI is a scoring system that takes
into account the localization, extent and severity of the skin
Table 1 - Demographic data of patients in the experimental and control groups.
Control (n = 40) Experimental (n = 40) p-value
Gender Female 22 (55.0) 25 (62.5) 0.650
Male 18 (45.0) 15 (37.5)
Age 40.60¡11.17 39.03¡14.84 0.593
Disease duration (years) - 8.13¡7.39 -
PASI - 22.05¡6.40 -
The data are presented as n (%) or as the mean¡standard deviation.
PASI: Psoriasis Activity and Severity Index.
Table 2 - Visual parameters of patients in the
experimental and control groups obtained via standard
achromatic perimetry and short wavelength automated
perimetry.
Control (n = 40) Experimental (n = 40) p-value
MD SAP -3.30¡2.12 -3.73¡2.19 0.376
SWAP -7.75¡4.17 -7.80¡3.40 0.953
PSD SAP 3.21¡1.34 3.23¡1.66 0.953
SWAP 3.55¡0.97 3.48¡0.97 0.749
CPSD SAP 2.23¡1.62 2.42¡1.85 0.633
SWAP 2.00¡1.44 2.32¡1.32 0.313
SF SAP 1.97¡0.71 1.70¡0.66 0.075
SWAP 2.33¡0.72 2.05¡0.72 0.092
The data are presented as the mean ¡ standard deviation.
SAP: standard achromatic perimetry; SWAP: short wavelength automated
perimetry; MD: mean deviation; PSD: pattern standard deviation; SF:
short-term fluctuation; CPSD: corrected pattern standard deviation.
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signs and provides a single score for psoriasis severity
ranging from 0 to 72 (12-14).
Abnormalities in the visual field may be observed in
patients with normal central vision. In recent years, the
sensitivity of SWAP was compared to that of SAP. SWAP
was found to be more sensitive for detecting early
glaucomatous and neuro-ophthalmologic visual field
changes and was able to reveal functional abnormalities in
the retina and optic nerve in patients with normal ocular
structures (15-18).
To the best of our knowledge, the visual field has not yet
been studied in psoriasis patients. We evaluated the visual
field of the study group using both SAP and SWAP and we
did not detect any statistically significant difference
between patients and controls; however, we found a
correlation between the visual field parameters and PASI.
Our study group consisted of patients with moderate
psoriasis, which might explain the statistically insignificant
intergroup difference in the visual field parameters. When
we examined the correlation between visual field para-
meters and disease activity and severity, we found a
negative correlation between the MD of both visual field
analyses and PASI. Retinal sensitivity appears to decrease
when psoriasis is exacerbated. We also found that the CPSD
and PSD of SWAP were positively correlated with PASI,
which may indicate localized defects in the visual field
during exacerbation periods. SWAP appears to be more
sensitive for detecting early functional changes in severe
and active psoriasis.
Psoriasis is known as a skin disease and it has been shown
to have a complex pathophysiology and a strong relation-
ship with proinflammatory cytokines, including tumor
necrosis factor-alpha (TNF-a), interferon-gamma (IFN-c)
and interleukins 6 and 8 (IL-6 and IL-8). Although one of the
limitations of the current study is the lack of data regarding
plasma proinflammatory cytokine levels of the study
subjects, the role of cytokines has been extensively studied
in patients with psoriasis. Serum TNF-a and IFN-c levels
were significantly higher in patients with active psoriasis
and these high serum levels were positively correlated with
the clinical severity and activity of the disease (19,20). The
serum levels of these cytokines were reported to serve as a
follow-up marker for monitoring disease severity (19,20).
Overexpression of TNF-a has been demonstrated in the
plasma and skin lesions of psoriatic patients (1,5,6,19,20)
and anti-TNF-a therapy has gained popularity in recent
years (1,6). TNF-a, an immunomediator and proinflamma-
tory cytokine, is a potent neurotoxic substance that induces
apoptotic cell death (21-25). IFN-c plays an important role in
autoimmune and infectious diseases (26). Animal studies
have shown that IFN-c induces apoptosis in the retinal
ganglion cell layer, resulting in photoreceptor loss and
disturbance of the axonal transport system of the affected
neurons (26,27). In addition, IL-8 induced cell death in
cultured neurons, while IL-6 stimulated oxidative stress (28-
31). The neurotoxic effects of these proinflammatory
cytokines have been implicated in the pathogenesis of
several central nervous system diseases, retinal ganglion cell
damage and optic nerve crush (21,22,28).
The inflammatory response and likely the increased
plasma levels of circulating proinflammatory cytokines, in
active and severe psoriasis seem to affect retinal functions
and decrease retinal sensitivity. Although the main target of
psoriasis is the skin, based on the results of the current
study, patients with psoriasis should undergo regular
ophthalmological examinations to examine their retinal
functions and identify potential ocular involvement.
Additional studies with a larger number of participants
should be performed to evaluate the retinal involvement
and roles of these cytokines in psoriatic patients.
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